




Did you find this useful? Give us your feedback
278 citations
115 citations
...Perry 1990 [44] USA Interview and questionnaire† 20 male weightlifters aged 18 to 28 years Gymnasium Human chorionic gonadotropin (hCG) Perry 2003 [45] USA Interview 10 male weightlifters aged 21 to 40 years Gymnasium Aspirin®, caffeine, clomiphene, creatine, dietary supplement, ephedrine, glutamine, liothyronine, protein powder, yohimbine Peters 1997 [46] Australia Interview and questionnaire† 100 persons (6 female) aged 18 to 50 years Advertisements, gymnasium, interviews, radio, sports shops and associations, syringe exchange centre Alcohol, aminogluthimide, amphetamine, antibiotics, beta blockers, caffeine, cannabis, chromium picolinate, clenbuterol, cocaine, daonil®, dietary supplement, diuretics, ecstasy, ephedrine, growth hormone, human chorionic gonadotropin (hCG), hydroxocobal amin, insulin-like growth factor 1, insulin, oestrogen antagonist, pregnyl®, proviron®, teroxin (T3), thyroxine Pope 1988 [47] USA Interview 41 male bodybuilders and footballers Gymnasium Alcohol, cannabis, cigarettes, cocaine, human chorionic gonadotropin (hCG) Pope 1994 [48] USA Interview 88 athletes; mean age 26 years Gymnasium Alcohol, cannabis, tobacco Rashid 2000 [49] USA Case study 40-year-old male Clinic Cocaine, cannabis, ‘uppers’, ‘downers’, lysergic acid diethylamide (LSD) Schäfer 2011 [50] Denmark Case study 26-year-old male bodybuilder Clinic Erythropoietin Silvester 1995 [51] USA Interview 22 former athletes aged 36 to 66 years Not specified Growth hormone Skårberg 2007 [52] Sweden Interview and questionnaire† 18 male drug users; mean age 35 years Clinic Alcohol, narcotics/other drugs Skårberg 2008 [53] Sweden Interview 6 drug users (2 female) Clinic Alcohol, amphetamine, analgesics, anti-catabolics, anti-oestrogens, aspirin®, benzodiazepines, bronchodilators, buprenorphine, caffeine, cannabis, cocaine, codeine, conjugated linoleic acid, creatine, dietary supplements, ecstasy, ephedra, ephedrine, growth hormone, Herbal products, insulin growth factor 1, insulin, protein powder, testosterone releasers Skårberg 2009 [54] Sweden Interview and questionnaire† 32 male drug users Clinic Alcohol, amphetamine, anti-oestrogen (clomid), analgesics, anti-acne drug, anti-catabolics, anti-depressants, anti-hypertensive drugs, anti-oestrogens, benzodiazepines, bronchodilators, cannabis, cocaine, creatine, dietary supplements, diuretics, ephedrine, fat-loss agents, gamma hydroxybutyrate, growth hormone, heroin, insulin, insulin-like growth factor 1, levodopa, muscle oil (synthol), non-steroidal anti-inflammatory drugs, opioid, plant steroid compounds, protein powder, stimulants, testosterone boosters, thyroid hormone Strauss 1985 [55] USA Interview 10 weight-trained female athletes; mean age 33 years Personal contact Acetaminophen, aspirin®, benoxaprofen, Ben-Gay®, caffeine, calcium, choline and inositol, dietary supplements, dimethyl S a g o e et a l. Su b sta n ce A b u se T rea tm en t, P reven tio n , a n d P o licy (2 0 1 5 ) 1 0 :1 2 P a g e 6 o f 1 9 Table 1 Characteristics of qualitative/descriptive studies presenting data on polypharmacy in AAS users (Continued) sulfoxide, codeine, electrolyte solution, epinephrine, furosemide, growth hormone, levodopa, lidocaine, naproxen, oxycodone hydrochloride, phenylbutazone, piroxicam, potassium, suntan pills, thyroglobulin, vitamins Tallon 2007 [56] Scotland Interview and questionnaire† 30 males aged 18 to 43 years; mean age 27 years Gymnasium Alcohol, cannabis, cocaine, clenbuterol, dietary supplements, diuretics, ecstasy, growth hormone, insulin, tamoxifen Wilson-Fearon 1999 [57] England Case study 29-year-old bodybuilder Not specified Clenbuterol, dietary supplements, diuretics, growth hormone, human chorionic gonadotropin (hCG), thiomucase Wines 1999 [58] USA Interview 11 weightlifters (5 female) aged 19 to 42 years Gymnasium Alcohol, buprenorphine, heroin, hydrocodone, nalbuphine, other drugs †We relied on the qualitative results generated from the interview....
[...]
...Clenbuterol Anabolic effects, burning fat, removing skin fluid, weight loss Chandler [12]; Gruber [21]; Kimergård [30]; Klötz [31]; Lenehan [36]; McBride [39]; Peters [46]; Wilson-Fearon [57] Anabolic effects, burning fat, removing skin fluid, weight loss Chandler [12]; Gruber [20-22]; Hope [25]; Kimergård [30]; Klötz [31]; Korkia [33]; Larance [35]; Lenehan [36]; McBride [39]; Peters [46]; Tallon [56]; Wilson-Fearon [57] 14...
[...]
...Sagoe et al. Substance Abuse Treatment, Prevention, and Policy (2015) 10:12 Page 9 of 19 Table 3 Use of non-AAS substances, reason(s)/motive(s) for use, and studies Current polypharmacy (Combined with AAS) Lifetime polypharmacy (Ever use) Substance Reason(s) for use Studies (First author, reference) Reason(s) for use Studies (First author, reference) Number of studies 2,4-dinitrophenol NS Chandler [12] NS Chandler [12]; Dunn [15]; Hope [25]; Larance [35] 4 Acetaminophen NS Strauss [55] NS Strauss [55] 1 Alcohol Better sleep and relaxation Chandler [12]; Hegazy [23]; Kanayama [28]; Kusserow [34]; Lundholm [37]; Malone [38]; Peters [46]; Perry [48]; Skårberg [52-54] Better sleep and relaxation Chandler [12]; Dunn [15]; Fudala [17]; Gruber [21,22]; Hegazy [23]; Hoff [24]; Hope [25]; Kanayama [26-28]; Katz [29]; Kusserow [34]; Malone [38]; Peters [46]; Perry [48]; Skårberg [52-54]; Tallon [56]; Wines [58] 23 Aminogluthimide Reducing receptors’ attraction to cortisol Peters [46] Reducing receptors’ attraction to cortisol Gruber [22]; Peters [46] 2 Amyl nitrate NS Chandler [12] NS Chandler [12] 1 Analgesics/opioids† Pain relief Ahlgrim [9]; Hegazy [23]; Kanayama [28]; Klötz [31]; Kusserow [34]; Lundholm [37]; Malone [38]; McBride [39]; Pappa [43]; Skårberg [53] Pain relief Ahlgrim [9]; Fudala [17]; Gruber [22]; Hegazy [23]; Kanayama [26,28], Klötz [31]; Kusserow [34]; Malone [38]; McBride [39]; Pappa [43]; Rashid [49]; Skårberg [53,54] 14 Anti-acne drugs† – – Combating acne Skårberg [54] 1 Antibiotics† Combating acne Peters [46] Combating acne Korkia [32]; Peters [46] 2 Anti-catabolics† NS Skårberg [53] Facilitating synthesis of hepatic protein and nitrogen economy Skårberg [53,54] 2 Anti-depressants† Combating side effects Klötz [31] Combating side effects, depression relief, boosting levels of serotonin and noradrenaline Klötz [31]; Skårberg [54] 2 Anti-oestrogens† Burning fat, combating gynecomastia, reducing effects on oestrogen Klötz [31]; Kusserow [34]; Peters [46]; Skårberg [53] Combating gynecomastia, burning fat, reducing effects on oestrogen Gårevik [18]; Hope [25]; Klötz [31]; Korkia [32]; Kusserow [34]; Larance [35]; Peters [46]; Skårberg [53,54] 9 Aromatase inhibitors† NS Chandler [12] NS Chandler [12] 1 Aspirin® NS Klötz [31]; Perry [45]; Skårberg [53]; Strauss [55] NS Klötz [31]; Larance [35]; Perry [45]; Skårberg [53]; Strauss [55] 5 Ben-Gay® NS Strauss [55] NS Strauss [55] 1 S a g o e et a l. Su b sta n ce A b u se T rea tm en t, P reven tio n , a n d P o licy (2 0 1 5 ) 1 0 :1 2 P a g e 1 0 o f 1 9 Table 3 Use of non-AAS substances, reason(s)/motive(s) for use, and studies (Continued) Benoxaprofen NS Strauss [55] NS Strauss [55] 1 Benzodiazepines† Better sleep, combating side effects, relaxation Klötz [31]; Larance [35]; Lundholm [37]; McBride [39]; Skårberg [53] Combating side effects, enhancing sleep and relaxation, self-control, sedation Gårevik [18]; Klötz [31]; Larance [35]; Lundholm [37]; Malone [38]; McBride [39]; Skårberg [53,54] 8 Beta blockers† Burning fat Peters [46] Burning fat Peters [46] 1 Beta-2-agonists† – – NS Bilard [11] 1 Blood pressure regulators† NS Kusserow [34] Lower blood pressure Kusserow [34]; Skårberg [54] 2 Bronchodilators† Energy and boosting training Skårberg [53] Burning fat, energy and boosting training, increasing strength Skårberg [53,54] 2 Buprenorphine NS Skårberg [53] NS Skårberg [53]; Wines [58] 2 Caffeine Burning fat Klötz [31]; Pappa [43]; Perry [45]; Peters [46]; Skårberg [53]; Strauss [55] Burning fat Gruber [22]; Klötz [31]; Larance [35]; Pappa [43]; Peters [46]; Perry [45]; Skårberg [53]; Strauss [55] 8 Calcium – – NS Strauss [55] 1 Cannabis/cannabinoids Enhancing sleep, relaxation Chandler [12]; Kanayama [27,28]; Klötz [31]; Kusserow [34]; Lundholm [37]; Malone [38]; McBride [39]; Pappa [43]; Peters [46]; Perry [48]; Skårberg [53,54] Enhancing sleep, relaxation Bilard [11]; Chandler [12]; Dunn [15]; Fudala [17]; Gruber [21,22]; Hoff [24]; Kanayama [27,28]; Klötz [31]; Kusserow [34]; Larance [35]; Malone [38]; McBride [39]; Pappa [43]; Peters [46]; Perry [48]; Rashid [49]; Skårberg [53,54]; Tallon [56] 21 Captopril NS Ahlgrim [9] NS Ahlgrim [9] 1 Carvedilol NS Ahlgrim [9] NS Ahlgrim [9] 1 Choline and inositol NS Strauss [55] NS Strauss [55] 1 Chromium picolinate Reducing body weight Peters [46] Reducing body weight Peters [46] 1 Clenbuterol Anabolic effects, burning fat, removing skin fluid, weight loss Chandler [12]; Gruber [21]; Kimergård [30]; Klötz [31]; Lenehan [36]; McBride [39]; Peters [46]; Wilson-Fearon [57] Anabolic effects, burning fat, removing skin fluid, weight loss Chandler [12]; Gruber [20-22]; Hope [25]; Kimergård [30]; Klötz [31]; Korkia [33]; Larance [35]; Lenehan [36]; McBride [39]; Peters [46]; Tallon [56]; Wilson-Fearon [57] 14 Clomiphene citrate NS Chandler [12]; Moss [41,42]; Perry [45] NS Chandler [12]; Moss [41,42]; Perry [45] 4 Cocaine Boosting training, burning fat, increasing strength Chandler [12]; Kanayama [28]; Larance [35]; Lundholm [37]; Malone [38]; Peters [46]; Skårberg [53,54] Boosting training, burning fat, increasing strength Chandler [12]; Dunn [15]; Fudala [17]; Gårevik [18]; Gruber [21]; Hoff [24]; Hope [25]; Kanayama [26-28]; Katz [29]; Larance [35]; Lundholm [37]; Malone [38]; Peters [46]; Rashid [49]; Skårberg [53,54]; Tallon [56] 19 Codeine Boosting training Skårberg [53]; Strauss [55] Boosting training Skårberg [53]; Strauss [55] 2 Conjugated linoleic acid Burning fat Skårberg [53] Burning fat Skårberg [53] 1 S a g o e et a l. Su b sta n ce A b u se T rea tm en t, P reven tio n , a n d P o licy (2 0 1 5 ) 1 0 :1 2 P a g e 1 1 o f 1 9 Table 3 Use of non-AAS substances, reason(s)/motive(s) for use, and studies (Continued) Corticosteroids† NS Lenehan [36] NS Bilard [11]; Korkia [32]; Lenehan [36] 3 Creatine Enhancing the effects of training Klötz [31]; Skårberg [53]; Perry [45] Anabolic effects, endurance booster, enhancing the effects of training, recovery aid Davies [14]; Filiault [16]; Hoff [24]; Klötz [31]; Perry [45]; Skårberg [53,54] 7 Daonil® Increasing insulin release Peters [46] Increasing insulin release Peters [46] 1 Dehydroepiandrosterone (DHEA) – – NS Larance [35] 1 Diazepam – – NS Gårevik [18] 1 Dietary/nutritional supplements† Energy and boosting training, nutrition Pappa [43]; Perry [45]; Peters [46]; Skårberg [53,54]; Strauss [55]; Wilson-Fearon [57] Energy and boosting training, anabolic effects, endurance booster, nutrition, recovery aid Davies [14]; Filiault [16]; Gruber [21]; Korkia [32]; Pappa [43]; Perry [45]; Peters [46]; Skårberg [53,54]; Strauss [55]; Tallon [56]; Wilson-Fearon [57] 12 Digoxin NS Ahlgrim [9] NS Ahlgrim [9] 1 Dimethyl sulfoxide NS Strauss [55] NS Strauss [55] 1 Diuretics† Combating side effects, masking doping drugs, reducing fluid levels Chandler [12]; Klötz [31]; Lenehan [36]; Pappa [43]; Peters [46]; Wilson-Fearon [57] Combating side effects, masking doping drugs, reducing fluid levels Chandler [12]; Goldfield [19]; Hope [25]; Klötz [31]; Korkia [32]; Larance [35]; Lenehan [36]; Pappa [43]; Peters [46]; Skårberg [54]; Tallon [56]; Wilson-Fearon [57] 12 Electrolyte solution NS Strauss [55] NS Strauss [55] 1 Ephedra/Ephedrine Energy and boosting training, enhancing weight loss Chandler [12]; Kimergård [30]; Klötz [31]; McBride [39]; Perry [45]; Peters [46]; Skårberg [53] Energy and boosting training, burning fat, enhancing weight loss, increasing strength Chandler [12]; Gårevik [18]; Gruber [20]; Gårevik [18]; Hope [25]; Kimergård [30]; Klötz [31]; Larance [35]; McBride [39]; Perry [45]; Peters [46]; Skårberg [53,54] 14 Epinephrine NS Strauss [55] NS Strauss [55] 1 Erythropoietin (EPO) NS Pappa [43]; Schäfer [50] NS Hope [25]; Pappa [43]; Schäfer [50] 3 Esiclene – – NS Korkia [32] 1 Fat-loss agents† – – Burning fat Skårberg [54] 1 Furosemide Weight loss Ahlgrim [9]; Strauss [55] Weight loss Ahlgrim [9]; McKillop [40]; Strauss [55] 3 Gamma hydroxybutyrate (GHB) Enhancing sleep Chandler [12]; Klötz [31]; Skårberg [54] Enhancing sleep Chandler [12]; Dunn [15]; Gruber [22]; Klötz [31]; Skårberg [54] 5 Genotropine NS Klötz [31] NS Klötz [31] 1 Glutamine NS Perry [45] NS Perry [45] 1 Growth hormone Anabolic effects and strength, burning fat, weight loss Chandler [12]; Kimergård [30]; Kusserow [34]; Lenehan [36]; Peters [46]; Skårberg [53,54]; Strauss [55]; Wilson-Fearon [57] Anabolic effects, burning fat, endurance booster, recovery aid, weight loss Chandler [12]; Filiault [16]; Fudala [17]; Gårevik [18]; Hope [25]; Kimergård [30]; Korkia [32,33]; Kusserow 18 S a g o e et a l. Su b sta n ce A b u se T rea tm en t, P reven tio n , a n d P o licy (2 0 1 5 ) 1 0 :1 2 P a g e 1 2 o f 1 9 Table 3 Use of non-AAS substances, reason(s)/motive(s) for use, and studies (Continued) [34]; Larance [35]; Lenehan [36]; Peters [46]; Silvester [51]; Skårberg [53,54]; Strauss [55]; Tallon [56]; Wilson-Fearon [57] Growth hormone releasing peptides† NS Chandler [12] NS Chandler [12] 1 Hallucinogens† NS Larance [35]; Malone [38] NS Dunn [15]; Larance [35]; Malone [38] 3 Herbal products† NS Skårberg [53] Increasing strength Skårberg [53,54] Heroin Enhancing sleep, pain relief Cornford [13]; Larance [35]; Skårberg [54] Enhancing sleep, pain relief Gårevik [18]; Cornford [13]; Kanayama [27]; Larance [35]; Skårberg [54]; Wines [58] 6 Human chorionic gonadotropin (hCG) Minimizing depressive symptoms upon AAS cessation/withdrawal, improving testosterone production, preventing weight loss, stopping testicular atrophy, increasing strength Chandler [12]; Kimergård [30]; Lenehan [36]; McBride [39]; Moss [41,42]; Perry [44]; Peters [46]; Perry [47]; Korkia [32]; Wilson-Fearon [57] Anabolic effects, increasing testosterone production, minimizing depressive symptoms upon AAS cessation/withdrawal, preventing weight loss, stopping testicular atrophy, increasing strength Chandler [12]; Fudala [17]; Gruber [22]; Gårevik [18]; Hope [25]; Kimergård [30]; Korkia [32]; Larance [35]; Lenehan [36]; McBride [39]; McKillop [40]; Moss [41,42]; Perry [44]; Peters [46]; Perry [47]; Wilson-Fearon [57] 17 Hydrochlorothiazide Weight loss Ahlgrim [9] Weight loss Ahlgrim [62] 1 Hydrocodone – – NS Wines [58] 1 Hydroxocobal amin Weight gain Peters [46] Weight gain Peters [46] 1 Inhalants† NS Larance [35] NS Dunn [15]; Larance [35] 2 Insulin Anabolic effects and strength, burning fat, weight loss Chandler [12]; Kimergård [30]; Klötz [31]; Peters [46]; Skårberg [53,54] Anabolic effects and strength, burning fat, weight loss Chandler [12]; Gårevik [18]; Hope [25]; Kimergård [30]; Klötz [31]; Larance [35]; Peters [46]; Skårberg [53,54]; Tallon [56] 10 Insulin-like growth factor 1 (IGF-1) Anabolic effects and strength, burning fat Chandler [12]; Klötz [31]; Lenehan [36]; Peters [46]; Skårberg [53,54] Anabolic effects and strength, burning fat Chandler [12]; Fudala [17]; Klötz [31]; Larance [35]; Lenehan [36]; Peters [46]; Skårberg [53,54] 8 Ketamine NS Chandler [12] NS Chandler [12]; Dunn [15] 2 Laxative – – NS Goldfield [19] 2 Levodopa NS Strauss [55] Increasing growth hormone Strauss [55]; Skårberg [54] 2 Lidocaine NS Strauss [55] NS Strauss [55] 2 Liothyronine NS Perry [45] NS Perry [45] 1 Lysergic acid diethylamide (LSD) NS Skårberg [54] NS Rashid [49]; Skårberg [54] 2 Mechano growth factor NS Chandler [12] NS Chandler [12] 1 S a g o e et a l. Su b sta n ce A b u se T rea tm en t, P reven tio n , a n d P o licy (2 0 1 5 ) 1 0 :1 2 P a g e 1 3 o f 1 9 Table 3 Use of non-AAS substances, reason(s)/motive(s) for use, and studies (Continued) Melanotan Boosting training, skin tanning Chandler [12]; Kimergård [30] Boosting training, skin tanning Chandler [12]; Hope [25]; Kimergård [30] 3 Mephedrone NS Chandler [12] NS Chandler [12] 1 Meth/amphetamine Alertness, boosting training, burning fat, increasing aggression during exercise, increasing strength, psychological wellbeing Chandler [12]; Hegazy [23]; Kimergård [30]; Larance [35]; Lundholm [37]; McBride [39]; Pappa [43]; Peters [46]; Skårberg [53,54] Alertness, boosting training, burning fat, increasing aggression during exercise, increasing strength, psychological wellbeing Angoorani [10]; Chandler [12]; Gårevik [18]; Hegazy [23]; Hoff [24]; Hope [25]; Kimergård [30]; Larance [35]; Lundholm [37]; McBride [39]; Pappa [43]; Peters [46]; Skårberg [53,54]; Tallon [56] 15 Muscle oil (synthol) – – Anabolic effect Skårberg [54] 1 Muscle relaxing drugs† Combating side effects Klötz [31] Combating side effects Klötz [31] 1 Myoblast NS Klötz [31] NS Klötz [31] 1 Nalbuphine/nubain® NS Strauss [55]; Lenehan [36]; McBride [39] Treating pain from weightlifting injuries, “anti-catabolic”, mental high Gruber [22]; Hope [25]; Kanayama [27]; Korkia [33]; Lenehan [36]; McBride [39]; Strauss [55]; Wines [58] 8 Naproxen NS Strauss [55] NS Strauss [55] 1 Non-steroidal antiinflammatory drugs (NSAIDs) † – – Inflammation, pain, and fever relief Skårberg [54] 1 Oxycodone NS Strauss [55] NS Kanayama [27]; Strauss [55] 2 Peptide hormones† – – NS Bilard [11] 1 Phenylbutazone NS Strauss [55] NS Strauss [55] 1 Phosphodiesterase-5 inhibitors (PDE5i) † – – NS Hope [25] 1 Piroxicam NS Strauss [55] NS Strauss [55] 1 Potassium NS Strauss [55] NS Strauss [55] 1 Potency/testicular increasing drugs† Combating side effects Klötz [31] Combating side effects Klötz [31] 1 Pregnyl® Improved testosterone production Peters [46] Improved testosterone production Peters [46] 1 Protein powder Enhancing effects of training, increasing protein synthesis Perry [45]; Skårberg [53,54] Enhancing effects of training, increasing protein synthesis Perry [45]; Skårberg [53,54] 3 Proviron® Hardiness, improved testosterone production Peters [46] Hardiness, improved testosterone production Peters [46] 1 Recovery drinks† – – Endurance booster, recovery aid Filiault [16] 1 Sedatives† NS Malone [38] NS Malone [38] 1 S a g o e et a l. Su b sta n ce A b u se T rea tm en t, P reven tio n , a n d P o licy (2 0 1 5 ) 1 0 :1 2 P a g e 1 4 o f 1 9 Table 3 Use of non-AAS substances, reason(s)/motive(s) for use, and studies (Continued) Sildenafil/viagra®/cialis Enhanced sexual functioning Chandler [12]; Kimergård [30] Enhanced sexual functioning Chandler [12]; Gårevik [18]; Hope [25]; Kimergård [30] 4 Somatotropine NS Klötz [31] NS Klötz [31] 1 Spironolactone Weight loss Ahlgrim [9] Weight loss Ahlgrim [9] 1 Stimulants† NS Klötz [31]; Kusserow [34]; Malone [38] Increasing strength, burning fat Fudala [17]; Klötz [31]; Kusserow [34]; Malone [38]; Rashid [49]; Skårberg [54] 6 Suntan pills† NS Strauss [55] NS Strauss [55] 1 Tamoxifen Combating side effects Chandler [12]; Kimergård [30]; Lenehan [36]; McBride [39] Combating side effects Chandler [12]; Gruber [22]; Kimergård [30]; Korkia [33]; Lenehan [36]; McBride [39]; Tallon [56] 7 Teroxin (T3) Preventing weight gain Peters [46] Preventing weight gain Peters [46] 1 Testosterone releasers/ boosters† Combating side effects, increasing hormone production Skårberg [53] Combating side effects, increasing blood serum levels of testosterone or hormone production Skårberg [53,54] 2 Thiazides† – – NS McKillop [40] 1 Thiomucase NS Wilson-Fearon [57] Burning fat Korkia [32,33]; Wilson-Fearon [57] 3 Thyroxine Burning fat, increasing metabolism Chandler [12]; Lenehan [36]; Peters [46]; Skårberg [54]; Strauss [55] Burning fat, increasing metabolism Chandler [12]; Gruber [22]; Hope [25]; Korkia [32]; Larance [35]; Lenehan [36]; McKillop [40]; Peters [46]; Skårberg [54]; Strauss [55] 10 Tobacco NS Malone [38]; Perry [48]; Pope [47] NS Malone [38]; Perry [48]; Pope [47] 3 Torsemide NS Ahlgrim [9] NS Ahlgrim [9] 1 Triacana – – NS Korkia [33] 1 Yohimbine NS Perry [45] NS Gruber [22]; Perry [45] 3 Other IPEDs, licit and illicit substances NS Kanayama [28]; Klötz [31]; Kusserow [34]; Perry [48]; Skårberg [52] NS Gruber [20,21]; Hoff [24]; Hope [25]; Kanayama [26,28]; Klötz [31]; Kusserow [34]; Perry [48]; Skårberg [52,54]; Wines [58] IPEDs: Image and performance-enhancing drugs....
[...]
...Ephedra/Ephedrine Energy and boosting training, enhancing weight loss Chandler [12]; Kimergård [30]; Klötz [31]; McBride [39]; Perry [45]; Peters [46]; Skårberg [53] Energy and boosting training, burning fat, enhancing weight loss, increasing strength Chandler [12]; Gårevik [18]; Gruber [20]; Gårevik [18]; Hope [25]; Kimergård [30]; Klötz [31]; Larance [35]; McBride [39]; Perry [45]; Peters [46]; Skårberg [53,54] 14...
[...]
...Growth hormone Anabolic effects and strength, burning fat, weight loss Chandler [12]; Kimergård [30]; Kusserow [34]; Lenehan [36]; Peters [46]; Skårberg [53,54]; Strauss [55]; Wilson-Fearon [57] Anabolic effects, burning fat, endurance booster, recovery aid, weight loss Chandler [12]; Filiault [16]; Fudala [17]; Gårevik [18]; Hope [25]; Kimergård [30]; Korkia [32,33]; Kusserow 18 S a g o e et a l....
[...]
114 citations
82 citations
...…2011; Christiansen & BojsenMøller, 2012; Cohen et al., 2007; Grogan, Shepherd, Evans, Wright, & Hunter, 2006; Ip, Barnett, Tenerowicz, & Perry, 2011; Kimergård, 2015; Kimergård & McVeigh, 2014; Nøkleby & Skårderud, 2013; Petrocelli, Oberweis, & Petrocelli, 2008; Sagoe, Andreassen, & Pallesen,…...
[...]
...The Well-being type bears resemblance to the typical AAS user described by Cohen et al. (2007), and the values he has are also dominant in the portraits of users described by e.g. Bilgrei (2013), Hoberman (2005), Kimergård (2015), Pedersen et al. (2014) and Walker and Joubert (2011)....
[...]
73 citations
...The year of publication of the studies ranged from 1980 [19] to 2014 [6-9,11]....
[...]
...Kimergård 2014 [6,8] 16 years; mean age 25 years Not specified Not specified Appearance, muscle, occupational, sports...
[...]
...…specified Sports Khorrami 2002 [30] Not specified Football, negative body image, weightlifting Gym employee Appearance, family influence, muscle, sports Kimergård 2014 [6,8] 16 years; mean age 25 years Not specified Not specified Appearance, muscle, occupational, sports Klötz 2010 [31] Not…...
[...]
...Kimergård 2014 [6,8] England and Wales Interview 24 males aged 21 to 61 years; mean age 34 years Gymnasium, prison, steroid clinic and charity, syringe exchange centre...
[...]
...Four recent studies [6-9] and five others [10-14] were later discovered and included in the analysis....
[...]
41,986 citations
...Written interview records were subjected to thematic content analysis in order to identify and verify themes relevant to the experiences of steroid usage (Burnard et al., 2008).3 Themes were continuously developed and refined as the study progressed (Miles & Huberman, 1994)....
[...]
2,763 citations
...Written interview records were subjected to thematic content analysis in order to identify and verify themes relevant to the experiences of steroid usage (Burnard et al., 2008).3 Themes were continuously developed and refined as the study progressed (Miles & Huberman, 1994)....
[...]
2,430 citations
...ness of information about the potential harms of these drugs from health authorities, and coping with insecurities about the use of these drugs by increasing the sense of security and well-being (Wills, 1981)....
[...]
...Overall, this appeared to serve multiple purposes, including questioning the trustworthiness of information about the potential harms of these drugs from health authorities, and coping with insecurities about the use of these drugs by increasing the sense of security and well-being (Wills, 1981)....
[...]
1,668 citations